Skip to main content
. 2015 Jul 14;6(29):27566–27579. doi: 10.18632/oncotarget.4491

Figure 6.

Figure 6

A. Overall survival of patients with a negative CXCR4 expression (IRS ≤ 2, n = 23) and of patients with a positive CXCR4 expression (IRS > 2, n = 37) B. Overall survival of patients with a negative SSTR2A expression (n = 6) and of patients with a positive SSTR2A expression (n = 54).